UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

Annals of oncology, 2018-08, Vol.29 (8), p.1658-1686

2018

Volltextzugriff (PDF)

Reply to ‘The challenge to one course carboplatin in seminoma clinical stage 1’ by Dieckmann and Anheuser

Annals of oncology, 2016-09, Vol.27 (9), p.1809-1809

2016

Volltextzugriff (PDF)

Ten thousand attentive hours, rapid learning, dissemination of knowledge and the future of experience-based care in germ-cell tumors

Annals of oncology, 2018-02, Vol.29 (2), p.289-290

2018

Volltextzugriff (PDF)

Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors

Annals of oncology, 2015-10, Vol.26 (10), p.2133-2140

2015

Volltextzugriff (PDF)

Primum non nocere: do we harm stage I testicular cancer patients less by applying adjuvant chemotherapy than by failing to present this option?

Annals of oncology, 2015-02, Vol.26 (2), p.255-256

2015

Volltextzugriff (PDF)

Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer

Annals of oncology, 2015-05, Vol.26 (5), p.833-838

2015

Volltextzugriff (PDF)

Increased risk of non-germ cell second cancer (SC) after cisplatin-based chemotherapy (CBCT) in 1-year testicular cancer (TC) survivors (TCS)

Annals of oncology, 2018-10, Vol.29, p.viii324-viii324

2018

Volltextzugriff (PDF)

2601 Outcome of relapses after adjuvant carboplatin in clinical stage I seminoma

European journal of cancer (1990), 2015-09, Vol.51, p.S511-S512

2015

Volltextzugriff (PDF)

Location and histology of retroperitoneal metastases in post-chemotherapy retroperitoneal lymph node dissection for non-seminoma germ cell tumour

European urology open science (Online), 2020-07, Vol.19, p.e395-e396

2020

Volltextzugriff (PDF)

735P Causes of death in a complete cohort of testicular cancer patients diagnosed in Norway 1980-2009, with detailed treatment information

Annals of oncology, 2023-10, Vol.34, p.S504-S504

2023

Volltextzugriff (PDF)

329P Pulmonary function and lung fibrosis up to 12 years after breast cancer radiotherapy

Annals of oncology, 2023-10, Vol.34, p.S315-S315

2023

Volltextzugriff (PDF)

Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance

Journal of clinical oncology, 2015-01, Vol.33 (1), p.51-57

2015

Volltextzugriff (PDF)

PO-1468 Influence of PSMA-PET on treatment of prostate cancer patients with biochemical recurrence

Radiotherapy and oncology, 2023-05, Vol.182, p.S1189-S1190

2023

Volltextzugriff (PDF)

Results from SWENOTECA V: A population-based protocol for seminomatous testicular cancer

JOURNAL OF CLINICAL ONCOLOGY, 2010, Vol.28 (15_suppl), p.4531-4531

2010

Volltextzugriff (PDF)

785P Thromboembolic events (TE) during treatment with cisplatin-based chemotherapy (CBCT) in metastatic testicular germ-cell cancer (TC)

Annals of oncology, 2020-09, Vol.31, p.S600-S600

2020

Volltextzugriff (PDF)

Primum Non Nocere: What Hurts in Clinical Stage I Testicular Cancer?

Journal of clinical oncology, 2015-07, Vol.33 (20), p.2318-2319

2015

Volltextzugriff (PDF)

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program (vol 27, pg 2122, 2009)

JOURNAL OF CLINICAL ONCOLOGY, 2009, Vol.27 (19), p.3263

2009

Volltextzugriff (PDF)

Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3525-3528

2017

Volltextzugriff (PDF)

Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1322-1331

2020

Volltextzugriff (PDF)

Primary retroperitoneal lymph node dissection (RPLND) in seminoma stage IIA-IIC ≤3cm: Combined results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) and Cologne

JOURNAL OF CLINICAL ONCOLOGY, 2023, Vol.41 (16_suppl), p.5008-5008

2023

Volltextzugriff (PDF)

The early results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) introduction of primary Retroperitoneal Lymph Node Dissection (RPLND) in seminoma stage IIA-IIb ≤ 3cm

European urology, 2023-02, Vol.83, p.S1068

2023

Volltextzugriff (PDF)

A0755 - The early results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) introduction of primary Retroperitoneal Lymph Node Dissection (RPLND) in seminoma stage IIA-IIb ≤ 3cm

European urology, 2023-02, Vol.83, p.S1068-S1068

2023

Volltextzugriff (PDF)

A0036 - Risk factors for relapse in non-seminomatous testicular cancer after post-chemotherapy retroperitoneal lymph node dissection with viable residual cancer

European urology, 2024-03, Vol.85, p.S724-S725

2024

Volltextzugriff (PDF)

Risk factors for relapse in non-seminomatous testicular cancer after post-chemotherapy retroperitoneal lymph node dissection with viable residual cancer

European urology, 2024-03, Vol.85, p.S724-S725

2024

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Aktive Filter

ThemaClinical Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Englisch
(129)
Norwegisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(57)
Humans
(33)
Oncology
(32)
Male
(29)
Medicin Och Hälsovetenskap
(24)
Adult
(15)
Testicular Neoplasms - Drug Therapy
(12)
Middle Aged
(11)
Testicular Neoplasms - Pathology
(10)
Urology & Nephrology
(10)
Adolescent
(9)
Young Adult
(9)
Aged
(8)
Neoplasm Staging
(8)
Prognosis
(8)
Testicular Cancer
(8)
Testicular Neoplasms - Mortality
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Neoplasms, Germ Cell And Embryonal - Drug Therapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

Reply to ‘The challenge to one course carboplatin in seminoma clinical stage 1’ by Dieckmann and Anheuser

Ten thousand attentive hours, rapid learning, dissemination of knowledge and the future of experience-based care in germ-cell tumors

Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors

Primum non nocere: do we harm stage I testicular cancer patients less by applying adjuvant chemotherapy than by failing to present this option?

Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer

Increased risk of non-germ cell second cancer (SC) after cisplatin-based chemotherapy (CBCT) in 1-year testicular cancer (TC) survivors (TCS)

2601 Outcome of relapses after adjuvant carboplatin in clinical stage I seminoma

Location and histology of retroperitoneal metastases in post-chemotherapy retroperitoneal lymph node dissection for non-seminoma germ cell tumour

735P Causes of death in a complete cohort of testicular cancer patients diagnosed in Norway 1980-2009, with detailed treatment information

329P Pulmonary function and lung fibrosis up to 12 years after breast cancer radiotherapy

Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance

PO-1468 Influence of PSMA-PET on treatment of prostate cancer patients with biochemical recurrence

Results from SWENOTECA V: A population-based protocol for seminomatous testicular cancer

785P Thromboembolic events (TE) during treatment with cisplatin-based chemotherapy (CBCT) in metastatic testicular germ-cell cancer (TC)

Primum Non Nocere: What Hurts in Clinical Stage I Testicular Cancer?

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program (vol 27, pg 2122, 2009)

Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm

Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma

Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer

Primary retroperitoneal lymph node dissection (RPLND) in seminoma stage IIA-IIC ≤3cm: Combined results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) and Cologne

The early results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) introduction of primary Retroperitoneal Lymph Node Dissection (RPLND) in seminoma stage IIA-IIb ≤ 3cm

A0755 - The early results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) introduction of primary Retroperitoneal Lymph Node Dissection (RPLND) in seminoma stage IIA-IIb ≤ 3cm

A0036 - Risk factors for relapse in non-seminomatous testicular cancer after post-chemotherapy retroperitoneal lymph node dissection with viable residual cancer

Risk factors for relapse in non-seminomatous testicular cancer after post-chemotherapy retroperitoneal lymph node dissection with viable residual cancer

Aktive Filter

Suchergebnisse filtern